| Oct 8, 2026 | Daniel Lippis | CVP, TAVR | SELL-OPTIONS | — | $79.17 | $8K |
| Sep 11, 2026 | Daniel Lippis | CVP, TAVR | SELL-OPTIONS | — | $80.09 | $9K |
| Aug 31, 2026 | Andrew Dahl | SVP, CORPORATE CONTROLLER | SELL | 544.000 | $91.06 | $50K |
| Aug 28, 2026 | Annette Bruls | CVP, EMEACLA | SELL | 2.644K | $89.98 | $238K |
| Aug 26, 2026 | Daveen Chopra | CVP, TMTT, SURGICAL & IHFM | SELL-OPTIONS | — | $81.85 | $583K |
| Aug 26, 2026 | Wayne Markowitz | CVP, JAPAC | SELL | 1.240K | $91.47 | $113K |
| Aug 11, 2026 | Daniel Lippis | CVP, TAVR | SELL-OPTIONS | — | $82.36 | $12K |
| Jul 30, 2026 | Wayne Markowitz | CVP, JAPAC | SELL | 146.313 | $86.03 | $13K |
| Jul 28, 2026 | Wayne Markowitz | CVP, JAPAC | SELL-OPTIONS | — | $79.54 | $106K |
| Jul 27, 2026 | Bernard Zovighian | CEO | SELL | 2.921K | $83.93 | $245K |
| Jul 10, 2026 | Daniel Lippis | CVP, TAVR | SELL-OPTIONS | — | $82.19 | $12K |
| Jun 30, 2026 | Daniel Lippis | CVP, TAVR | SELL-OPTIONS | — | $82.04 | $12K |
| Jun 17, 2026 | Bernard Zovighian | CEO | SELL | 523.000 | $87.92 | $46K |
| May 29, 2026 | Andrew Dahl | SVP, CORPORATE CONTROLLER | SELL | 567.527 | $86.08 | $49K |
| May 27, 2026 | DONALD BOBO JR | CVP,STRATEGY/CORP DEVELOPMENT | SELL | 23.145K | $86.42 | $2.0M |
| May 22, 2026 | Daveen Chopra | CVP, TMTT & SURGICAL | SELL | 1.500K | $84.60 | $127K |
| May 18, 2026 | Daniel Lippis | CVP, TAVR | SELL-OPTIONS | — | $76.91 | $5K |
| May 15, 2026 | DONALD BOBO JR | CVP,STRATEGY/CORP DEVELOPMENT | SELL | 17.968K | $81.96 | $1.5M |
| May 11, 2026 | Bernard Zovighian | CEO | SELL | 15.342K | $78.78 | $4.9M |
| May 7, 2026 | Wayne Markowitz | CVP, JAPAC | GRANT | 4.117K | $81.21 | $88K |
| May 1, 2026 | Daniel Lippis | CVP, TAVR | SELL | 252.000 | $71.40 | $71K |
